European regulators approve Humira for psoriasis

12/20/2007 | Forbes · Reuters

Abbott Laboratories has obtained European Commission approval to market its injectable rheumatoid arthritis drug, Humira, as a treatment for moderate to severe psoriasis. The drug was effective in clearing 75% or more of inflamed red skin lesions in more than three-fourths of patients during a clinical trial, according to Abbott.

View Full Article in:

Forbes · Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Sr. Principal OptoMechanical Engineer - 14000008M2
Abbott
San Jose, CA
Director, Compliance - Health Plan Privacy & Security
Kaiser Permanente
Oakland, CA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC